Test ID TPSF Protein, Total, Spinal Fluid
Useful For
To detect increased permeability of the blood-brain barrier to plasma proteins
To detect increased intrathecal production of immunoglobulins
Method Name
Reflectance Spectrophotometry
Reporting Name
Protein, Total, CSFSpecimen Type
CSFContainer/Tube: Sterile vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge specimen to remove any cellular material.
Specimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
CSF | Refrigerated (preferred) | 72 hours |
Frozen | 180 days |
Clinical Information
Cerebrospinal fluid (CSF) is secreted by the choroid plexuses, around the cerebral vessels, and along the walls of the ventricles of the brain. It fills the ventricles and cisternae, bathes the spinal cord, and is reabsorbed into the blood through the arachnoid villi. CSF turnover is rapid, exchanging about four times per day. More than 80% of CSF protein content originates from plasma by ultrafiltration through the walls of capillaries in the meninges and choroid plexuses; the remainder originates from intrathecal synthesis. Because CSF is mainly an ultrafiltrate of plasma, low-molecular plasma proteins such as prealbumin, albumin, and transferrin predominate. No protein with a molecular weight greater than that of IgG is present in sufficient concentration to be visible on electrophoresis.
The permeability of the blood-brain barrier to plasma proteins is increased by high intracranial pressure due to brain tumor; intracerebral hemorrhage; traumatic injury; or by inflammation due to bacterial or viral meningitis, encephalitis, or poliomyelitis.
Increased intrathecal synthesis of immunoglobulins, particularly IgG, is seen in demyelinating diseases of the central nervous system (CNS), especially multiple sclerosis. Increased immunoglobulins are also seen in other chronic inflammatory diseases of the CNS such as chronic meningoencephalitis due to bacteria, viruses, fungi or parasites; subacute sclerosing panencephalitis; and Guillian-Barre syndrome.
Reference Values
≥12 months: 0-35 mg/dL
Reference values have not been established for patients that are <12 months of age.
Cautions
Specimens should be collected prior to the intrathecal administration of contrast media. Significant positive bias can occur when cerebrospinal fluid (CSF) contains contrast media. If possible, the patient should be recumbent for about one hour before the specimen is drawn. Erect posture causes a redistribution of the body fluid, increasing total serum protein concentration.
Blood in the CSF specimen invalidates the protein value.
Day(s) Performed
Monday through Sunday; Continuously
Report Available
Same day/1 dayPerforming Laboratory

Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84157